PADnet is designed to uncover hidden peripheral vascular disease through a non-invasive physiologic test.
We offer a fully-customizable program that leverages our network of 1000+ providers and clinics to enable progressive health systems and plans identify chronic conditions in their patient populations.
Don’t think of this product or service as your third favorite, think of it as the bronze medalist in an Olympic medals sweep of great products/services.
Biomedix solutions and systems are designed to securely transmits test data and patient history to a specialist for remote interpretation, saving time and eliminating the need for travel to a hospital or specialty lab for baseline testing. The relationship created between physician and specialist through this network promotes more efficient, coordinated patient care. 
This is should be a prospective customer’s number one call to action, e.g., requesting a quote or perusing your product catalog.
“I had a male patient with severe intermittent claudication, he could not walk more than two blocks without pain. He was seeing a vascular surgeon who only did open vascular procedures. The surgeon instructed the patient that nothing could be done, which caused the patient to get very depressed. I performed a PADnet test, revealing a severe tibio-peroneal stenosis. I sent him to an interventional cardiologist. The patient had stents implanted in both extremities, each leg done a few weeks apart. The patient returned a few weeks later, and actually hugged me! He now walks in the local park everyday with minimal symptoms.”
"A unique feature of PADnet is its ability to break down barriers between specialists and primary physicians. Biomedix will train your staff. That makes a huge difference. They provide that comfort level with testing, and once they get that, they are off and running."
“I had a female patient that was complaining of symptoms of intermittent claudication. She said she couldn’t walk more than 30 feet before her legs started to hurt and that she couldn’t walk to the store by her house anymore. She said it had been gradually getting worse, so I did a PADnet study. It showed moderate to severe bilateral peripheral artery disease. She was referred to an interventional cardiologist who performed revascularization procedures on both her legs. On her next visit she thanked me for doing the test and for sending her for treatment. She now has no leg pain with walking and has returned to her normal daily activities.”
"This helps support the way we work. Three of our five offices are part of multi-specialty groups. I can test a patient in one office, and review the results with a specialist in another office without having to carry copies with me."
“As a PADnet technician I am proud to be able to offer this valuable screening service to our patients. I find that few patients are aware of the very real dangers associated with PAD and many don’t recognize the symptoms. It’s important to continue to raise awareness and educate all patients, especially those at greatest risk for developing this disease, about the dangers of PAD and ways to avoid or treat it.”
"The results can read by a vascular specialist of your choice via the Internet helping to increase referrals and reduce liability."
Smokeless tobacco use is linked to a significantly higher risk of peripheral artery disease, with PAD incidence comparable to cigarette smoking, highlighting the need for early screening.
Short sleep duration is linked to higher peripheral artery disease risk, highlighting sleep as a modifiable factor and the need for early PAD screening.
Peripheral artery disease (PAD) is a serious complication of diabetes that significantly increases mortality risk. Diabetic patients often experience impaired circulation, which can lead to non-healing wounds, infections, and ultimately amputations. These vascular issues also raise the likelihood of cardiovascular events such as heart attacks and strokes. Early detection and intervention are critical—screening for PAD in high-risk populations (diabetics, smokers, patients over 65) can prevent severe outcomes and reduce healthcare costs. Clinicians are encouraged to integrate PAD testing into routine care to improve patient survival and quality of life.
